Our highest priority is the health and safety of our attendees, speakers, pharma partners, their families and the MECC/MEC team.
We are monitoring guidance from the CDC and other authorities in regard to the Coronavirus developments. The situation regarding COVID-19 is fluid and ever-changing and we will remain open as new information and guidelines emerge and follow best practices.
Please stay tuned on conference information that may be updated periodically.
If you have any questions, please do not hesitate to contact us via email firstname.lastname@example.org.